Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05IBQ
|
||||
Former ID |
DNC011563
|
||||
Drug Name |
(D)Arg-Arg-Pro-Hyp-Gly-Thi-Ser-(D)Tic-Tic-Arg
|
||||
Indication | Discovery agent | Investigative | [529475] | ||
Structure |
Download2D MOL |
||||
Formula |
C60H85N19O13S
|
||||
Canonical SMILES |
C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N<br />2CC(CC2C(=O)NCC(=O)NC(CC3=CC=CS3)C(=O)NC(CO)C(=O)N4CC5=<br />CC=CC=C5CC4C(=O)N6CC7=CC=CC=C7CC6C(=O)NC(CCCN=C(N)N)C(=<br />O)O)O
|
||||
InChI |
1S/C60H85N19O13S/c61-39(15-5-19-68-58(62)63)49(83)73-40(16-6-20-69-59(64)65)53(87)76-22-8-18-44(76)55(89)79-31-37(81)26-46(79)51(85)71-28-48(82)72-42(27-38-14-9-23-93-38)50(84)75-43(32-80)54(88)78-30-36-13-4-2-11-34(36)25-47(78)56(90)77-29-35-12-3-1-10-33(35)24-45(77)52(86)74-41(57(91)92)17-7-21-70-60(66)67/h1-4,9-14,23,37,39-47,80-81H,5-8,15-22,24-32,61H2,(H,71,85)(H,72,82)(H,73,83)(H,74,86)(H,75,84)(H,91,92)(H4,62,63,68)(H4,64,65,69)(H4,66,67,70)/t37?,39-,40-,41?,42?,43-,44-,45?,46-,47?/m1/s1
|
||||
InChIKey |
GFWURPIOGZMEAS-RFHUBXOQSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | B2 bradykinin receptor | Target Info | Inhibitor | [529475] | |
KEGG Pathway | Calcium signaling pathway | ||||
cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Complement and coagulation cascades | |||||
Inflammatory mediator regulation of TRP channels | |||||
Regulation of actin cytoskeleton | |||||
Endocrine and other factor-regulated calcium reabsorption | |||||
Chagas disease (American trypanosomiasis) | |||||
Pathways in cancer | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Direct p53 effectors | ||||
Validated transcriptional targets of deltaNp63 isoforms | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.